June 19th 2024
A survey of health system specialty pharmacy employees found that hybrid work significantly improved quality of life and workplace productivity.
NABP e-profile IDs make it easier to get CPE credit
June 15th 2011A new continuing education reporting system sponsored by NABP and ACPE should be in use by the end of the year. In order to receive credit for CPE activities, applicants will provide their NABP e-Profile ID and date of birth. IDs may be obtained at the NABP website.
Two new molecular entities treat hypertension and COPD
June 15th 2011FDA has approved azilsartan medoxomil 40-mg and 80-mg tablets for the treatment of hypertension, either alone or in combination with other antihypertensive agents. FDA has also approved roflumilast as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations (not the relief of acute bronchospasm).
Drug Topics releases top 200 branded and generic drug lists
June 14th 2011Despite a drop in the number of prescriptions written for the top 10 branded drugs in 2010 compared with 2009, there were gains in terms of retail dollars among most of the manufacturers of the top 10 products, according to the Drug Topics top 200 branded drugs lists.
Study finds unexpectedly high risk of hypertension for young adults
June 7th 2011Nearly 20% of young adults in the United States may have high blood pressure, according to the National Longitudinal Study of Adolescent Health, an analysis sponsored by the National Institutes of Health and published online in Epidemiology.
TV-based patient education improves engagement, quality of care
May 26th 2011Integrated television-based technology can help hospitals meet the patient-centeredness requirements of federal reform initiatives, stated a recent white paper released by LodgeNet Healthcare, a provider of media and connectivity solutions for hospitals.
HIV infection risk for uninfected sex partners reduced by early ART
May 26th 2011Early commencement of oral antiretroviral therapy by men and women infected with HIV substantially reduced the risk that they would transmit the virus to their uninfected sexual partners, according to findings from a large multinational clinical study conducted by the HIV Prevention Trials Network.